Demet Sag

I am dedicated to transforming scientific discoveries into real-world medical solutions. My work integrates genomics, stem cell biology, immune profiling, and translational medicine to build precision diagnostics and therapeutics that address complex diseases. As the Founder of genome2life, I focus on developing point-of-care technologies and precision medicine platforms with strong applications in women’s health, oncology, and autoimmune disorders.

Through Functional TransGenomics and my advisory roles, I collaborate with global researchers, clinicians, startups, and investors to advance regulatory strategy, clinical development, and commercialization of innovative life science technologies. My mission is to accelerate the translation of cutting-edge science into scalable healthcare solutions that improve patient outcomes and drive impactful growth in the biotechnology ecosystem.